Atra stock forecast.

22 nov 2023 ... Benchmark actually lowered its SEEL stock forecast price to $1 and has a Speculative Buy rating. ... Tags ATRA, ATRA stock, how to find penny ...Earnings Date. Feb 06, 2024 - Feb 12, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 3.94. Fair Value is the appropriate price for the shares of a company, based ... All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Stock Price Forecast. The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 14.30, with a high estimate of 21.00 and a low estimate of 7.60. The median ...As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.

Atara Biotherapeutics Inc. Watch list Set a price target alert After Hours Last Updated: Nov 22, 2023 7:55 p.m. EST Delayed quote $ 0.5402 -0.03 -5.56% After Hours Volume: 53.15K Advanced...

The current average ATRA price target, as estimated by these analysts, is $3.00. The predictions for the future ATRA stock price range from a low of $3.00 to a high of $3.00, highlighting the variability of market expectations for ATRA. Analyst projections state that ATRA is forecast to be at a low of $0.40 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -4207.69% from its current level, while the stock would need to crash 38.46% from its current level to reach the projected low.

During the last day, the stock moved $0.1000 between high and low, or 1.40%. For the last week, the stock has had daily average volatility of 1.24% . Our recommended stop-loss: $6.83 (-5.75%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 19 days ago.)12/02/2023. Palantir stock price stood at $20.27. According to the latest long-term forecast, Palantir price will hit $25 by the end of 2023 and then $30 by the middle of 2025. Palantir will rise to $45 within the year of 2026, $55 in 2027, $60 in 2028, $65 in 2029, $70 in 2030, $75 in 2032, $80 in 2033, $85 in 2034 and $90 in 2035.19 equities research analysts have issued 1 year target prices for Paramount Global's stock. Their PARA share price targets range from $9.00 to $30.00. On average, they predict the company's stock price to reach $15.72 in the next twelve months. This suggests that the stock has a possible downside of 0.4%.Atara Biotherapeutics (NasdaqGS:ATRA) Stock Forecast & Analyst Predictions - Simply Wall St View Valuation Atara Biotherapeutics Future Growth Future …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...

Discover historical prices for ATRA stock on Yahoo Finance. View daily, weekly or monthly format back to when Atara Biotherapeutics, Inc. stock was issued.

Find the latest Atara Biotherapeutics, Inc. ATRA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. …

Mar 30, 2023 · Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. 25 abr 2023 ... Atrás. Cuenta de Cloud Iniciar sesión en ... Proper inventory management involves active monitoring of stocks, the use of technology to forecast ...THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its …Stock Price Forecast The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ... 7 equities research analysts have issued 12-month price targets for Luminar Technologies' stock. Their LAZR share price targets range from $3.00 to $20.00. On average, they expect the company's stock price to reach $11.71 in the next twelve months. This suggests a possible upside of 376.2% from the stock's current price.Mizuho Securities analyst Salim Syed has maintained their bullish stance on ATRA stock, giving a Buy rating on September 26.. Salim Syed’s rating of Atara Biotherapeutics as a Buy is driven by a ...On average, Wall Street analysts predict that Atara Biotherapeutics 's share price could reach $11.18 by Nov 10, 2024. The average Atara Biotherapeutics stock price …

GDX Signals & Forecast. Mostly positive signals in the chart today. The VanEck Vectors Gold Miners ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long …Nov 24, 2023 · THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare Conference 4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.Nov 24, 2023 · THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare Conference Discover historical prices for ATRA stock on Yahoo Finance. View daily, weekly or monthly format back to when Atara Biotherapeutics, Inc. stock was issued.Atara Biotherapeutics Inc. (ATRA) Company Description. Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188 ...

GDX Signals & Forecast. Mostly positive signals in the chart today. The VanEck Vectors Gold Miners ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long …

HRTX Stock 12 Months Forecast. $9.00. (1402.00% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Heron Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 1402.00% change from the last price of $0.60.Based on the future market’s prediction, the third quarter of 2023 will see the interest peak at around 3.8%. Source: ASX. However, the months ahead in the new calendar will also have the opportunity to see the inception point finally arrived for the local monetary policy. Even with the absence of the first rate-cut to occur, the pause of the ...Spacecraft engine manufacturer and small rocket builder Astra plans to conduct a reverse stock split at a 1 to 15 ratio. Astra also seeks to raise up to $65 million through an "at the market ...The FuelCell stock price gained 3.31% on the last trading day (Wednesday, 29th Nov 2023), rising from $1.21 to $1.25.During the last trading day the stock fluctuated 7.88% from a day low at $1.21 to a day high of $1.30.The price has risen in 5 of the last 10 days and is up by 0.81% over the past 2 weeks. Volume fell on the last day by -79 …Mullen Automotive Stock Forecast. Stock Price Forecast. There is currently no analyst price target forecast available for MULN stock. Analyst Consensus: n/a. Target Low Average Median High; Price: n/a: n/a: n/a: n/a: Change: n/a: n/a: n/a: n/a: Analyst Ratings. There are currently no analyst ratings available for MULN. Recommendation …16 sept 2020 ... See if the stock goes on to build a promising consolidation that could kick off a new price move. Atara Biotherapeutics (ATRA).Nov 24, 2023 · Atara Biotherapeutics Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.57. Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.481%. Pessimistic target level: 0.56. Optimistic target level: 0.58. Nov 16, 2023 · With Atara Biotherapeutics stock trading at $0.38 per share, the total value of Atara Biotherapeutics stock (market capitalization) is $38.73M. Atara Biotherapeutics stock was originally listed at a price of $10.65 in Oct 16, 2014. If you had invested in Atara Biotherapeutics stock at $10.65, your return over the last 9 years would have been ... 19 equities research analysts have issued 1 year target prices for Paramount Global's stock. Their PARA share price targets range from $9.00 to $30.00. On average, they predict the company's stock price to reach $15.72 in the next twelve months. This suggests that the stock has a possible downside of 0.4%.

4 ago 2022 ... " Stock price fell from $12.85 per share to $10.21 per share the next trading day, as the market reacted negatively to this prediction. On ...

Spacecraft engine manufacturer and small rocket builder Astra plans to conduct a reverse stock split at a 1 to 15 ratio. Astra also seeks to raise up to $65 million through an "at the market ...

Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.Mar 30, 2023 · Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Rivian Automotive Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 18.63. Negative dynamics for Rivian Automotive shares will prevail with possible volatility of 5.691%. Pessimistic target level: 18.06. Optimistic target level: 19.15.ATRA Stock 12 Months Forecast. $5.05. (890.20% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $5.05 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 890.20% change from the last price of $0.51.P.O. Box 505000. Louisville, KY 40233. T: (781) 575-2879. [email protected]. Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions, including multiple sclerosis, that can be rapidly delivered to patients within …Find real-time ALDX - Aldeyra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Atara Biotherapeutics Stock Forecast. Is Atara Biotherapeutics Stock Undervalued? The current Atara Biotherapeutics [ ATRA] share price is $0.65. The Score for ATRA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal. ATRA is currently trading in the 10-20% percentile range relative to its historical ...In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.According to 30 stock analysts, the average 12-month stock price forecast for Tesla stock is $238.87, which predicts a decrease of -2.16%. The lowest target is $85 and the highest is $380. On average, analysts rate Tesla stock as a hold.

34 Wall Street research analysts have issued 12 month price objectives for PayPal's stock. Their PYPL share price targets range from $55.00 to $118.00. On average, they expect the company's share price to reach $78.77 in the next year. This suggests a possible upside of 32.0% from the stock's current price.Find real-time ALDX - Aldeyra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. This should extend its cash runway past the third quarter of 2025. ATRA stock is down 50.4% as of Thursday morning with some 3.1 million shares traded. For comparison, its daily average trading ...Instagram:https://instagram. top dow stocksvalue of a copper pennystock auto traderinvest in real estate with no money Nov 23, 2023 · High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year. fast company innovation festival 2023how much are 1979 dollar coins worth Fuelcell Energy Inc () Stock Market info Recommendations: Buy or sell Fuelcell Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Fuelcell Energy share forecasts, stock quote and buy / sell signals below.According to present data Fuelcell Energy's FCEL shares and potentially its market environment have … tltw dividend history On November 2, 2023, Atara Biotherapeutics Inc (ATRA) experienced a significant surge in its stock performance following positive price forecasts from analysts. According to data from CNN Money, seven analysts have offered 12-month price forecasts for ATRA, with a median target of $19.00.What is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 (6.14%) Updated Nov 17, 2023 04:00 PM ET...Oct 27, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.